Point72 Middle East FZE’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-64,685
Closed -$16M 1641
2023
Q3
$15.9M Buy
+64,685
New +$17.7M 0.52% 31
2023
Q1
Sell
-464
Closed -$118K 1857
2022
Q4
$111K Buy
+464
New +$104K ﹤0.01% 1233

Other funds holding HCA

Point72 Middle East FZE's HCA Position: Q4 2023 in Review

Point72 Middle East FZE sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 64,685 shares — an estimated $16M sold.

Point72 Middle East FZE first reported a position in HCA in Q4 2022 and held it in 2 quarters. The position peaked at $15.9M in Q3 2023. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Point72 Middle East FZE reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 64,685 HCA Healthcare shares in Q4 2023, an estimated $16M.
  • Point72 Middle East FZE first reported a position in HCA Healthcare in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's HCA Healthcare position peaked at $15.9M in Q3 2023.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.